Virbac has launched Prinovox, a new prescription-only spot-on ectoparasiticide for dogs and cats.

The company says the new product contains the same combination of Moxidectin and Imidacloprid as the market leader, but is offered with a unique and innovative pet owner engagement programme to help practices build loyalty, increase compliance and to encourage repeat purchase.

In dogs Prinovox is licensed for the treatment and prevention of lungworm; for the treatment and prevention of fleas and also for lice, mites, heartworm and roundworms. In cats, the licence covers fleas, mites, roundworm and heart worm. It can also be used for fleas and heartworm in ferrets.

Prinovox is available in six presentations to suit all weight ranges and in packs of four pipettes. The packaging uses the Blippar platform which owners can use to 'blip' interactive icons on the product's packaging with their smartphone to get more information on Prinovox, including a video on how to use it, a reminder system and a game.

In addition, the Prinovox support package includes:

• A Client Prinovox Kit to be given to clients on purchase, which includes educational information, competitions and collectable items
• Two suites of in-practice display materials, including posters, character-based leaflet dispensers and collectables to encourage family involvement
• A Kids Club which invites children to become members of the' Creepy Crawley Intelligence Agency' (CCIA). Members receive four activity packs a year in addition to competitions and collectable items.

Virbac's Head of Marketing Companion Animal, Simon Boulton MRCVS said: "We see the launch of Prinovox as a gamechanger. The ectoparasiticide market is one of the largest and most competitive in our industry and we are the first company to offer a product with the same efficacy as the market leader for all indications.

"We've gone one step further by increasing the value of the product to practices by developing a comprehensive parasite protection support package which harnesses the latest technology and consumer preferences for receiving information. We believe the efficacy of Prinovox, combined with the innovative support package we're offering, will make it a highly attractive product for practices and owners and we've been delighted at the feedback we've received so far."

The Royal Veterinary College (RVC) has published research which sheds light on the frequency, risk factors and linked health problems associated with periodontal disease in pet cats in the UK.

RVC researchers say that the VetCompass study is the largest ever carried out into dental disease in cats using veterinary clinical records.

The study investigated a sample of 18,249 cats randomly selected from a study population of 1,255,130 cats in the UK in 2019.

Periodontal disease was recorded in 15.2% of the sample making it the most common disorder. 

The cat breeds with the highest annual levels of this diagnosis were Siamese (18.7%), Maine Coon (16.7%) and British Short Hair (15.5%) as well as crossbreeds (15.4%).

The average bodyweight of cats with periodontal disease (5.7kg) was higher than for cats without periodontal disease (5.5kg).

The risk of periodontal disease rose steeply as cats got older, with cats aged 9 to 12 years being 6.7 times more likely to have periodontal disease compared with cats aged under 3 years.

Cats with periodontal disease were much more likely to have a range of other health conditions compared to cats without periodontal disease (x 1.8 risk).

These conditions included cardiac dysrhythmia (x 2.3 risk), ear discharge (x 2.3 risk) and hairball/furball (x 2.3 risk).

The researchers say that these findings suggest that periodontal disease should be acknowledged as a leading health and welfare issue in cats, and highlight the need for greater dental care in cats as they age. 

The study was supported by an award from the Kennel Club Charitable Trust and Agria Pet Insurance.

The Privy Council has approved a Recognition Order for the University of Surrey’s veterinary degree and it will be formally accredited by the RCVS from late next month.

The new Order will come into force on the 18th February 2020, from when students who graduate with the University of Surrey’s veterinary degree will automatically be able to join the Register of Veterinary Surgeons and to practise veterinary medicine in the UK.

The university’s Bachelor of Veterinary Medicine and Science (BVMSci Hons) degree will enter the College’s cyclical accreditation process and be subject to annual monitoring for quality assurance.

Accreditation of the degree was a five-year process during which the RCVS worked with the University of Surrey to ensure that its curriculum and programme met the College’s quality standards, including two interim accreditation visitations in 2017 and 2018 and a final accreditation visit in 2019.

Dr Niall Connell, RCVS President, said: “We are very glad that the University of Surrey’s veterinary degree has now cleared the last hurdle and that, as of next month, it will join the roster as the UK’s eighth recognised veterinary degree. I commend the hard work that the faculty, students and the university’s clinical partners have put in to develop the course over the past five years and we look forward to continue to work with them to ensure that the high standards are maintained."

Professor Chris Proudman, Head of the School of Veterinary Medicine at the University of Surrey, said: "I am delighted that the University of Surrey’s School of Veterinary Medicine has become the UK’s eighth provider of veterinary education. The support and enthusiasm of our partner practice network has been essential in delivering our vision of competent, confident and compassionate veterinary graduates."

The full RCVS accreditation standards for veterinary degrees can be found here: www.rcvs.org.uk/setting-standards/accrediting-primary-qualifications/accrediting-veterinary-degrees/accreditation-standards/

Photo: (from l-r) Susan Paterson, Chair of the RCVS Education Committee, Professor Chris Proudman, Head of the School of Veterinary Medicine at the University of Surrey, and Niall Connell, RCVS President.

Kent-based equine vet Katie Preston will be competing at the world-famous Badminton Horse Trials (1st-5th May).

Katie, who works at Milbourn Equine, is now preparing with her horse Templar Justice, or TJ for short, to take part in what is widely acknowledged to be one of the world's most difficult equestrian events.

Last year, she competed at the Burghley Horse Trials and was voted "Amateur Rider of the Year" by Horse and Hound magazine. 

Katie says she is determined to build on that success with a strong showing at Badminton: "The Burghley Horse Trials were amazing last year. I was so excited to be there and it went so well. To now be competing at Badminton will be an awesome experience. 

"It’s one of only six 'five-star' equestrian events in the world and to compete there really is my dream come true."

The Royal Veterinary College has been named as the top veterinary school in the QS World University Rankings 2021.

Compiled by global higher education analysts, QS Quacquarelli Symonds, the rankings provide a comparative analysis on the performance of 14,435 individual university programs, taken by students at 1,452 universities in 86 locations around the world, across 51 academic disciplines and five broad Faculty Areas. The rankings are determined by a range of criteria, including academic reputation, research impact, number of citations, employer reputation and the h-index. 

In addition to maintaining a perfect score for the Academic Reputation indicator (100) for a second year running, the RVC saw improvements across every category. Research impact was recognised with the RVC scoring 98.9 in Citations per Paper. This was supported by the 97.5 score for h-index, surpassing 2020’s 96.9.

Rankings for Employer Reputation also increased by 29% since 2020, with the RVC now scoring 83.3.

Professor Stuart Reid, Principal of the RVC, said: "Last year, we made a commitment to redouble our efforts in seeking to regain the top spot in the QS rankings, and I am delighted that we have achieved it. This would be remarkable in normal times but, in the context of COVID-19, it is all the more so and a real tribute to the whole RVC community.

"It is the result of enormous efforts made by all RVC staff and students, and I could not be prouder to be Principal of the RVC. The QS rankings are important for our reputation and international standings. With so many outstanding veterinary schools worldwide and with peer recognition one of the metrics, it is particularly pleasing to be first amongst equals."

The full set of rankings can be found at: https://www.topuniversities.com/subject-rankings/2021

Defra has confirmed that equine infectious anaemia (EIA) has been detected in two horses in Wiltshire following importation from Romania via Belgium.

The premises is currently under restriction and the two infected horses will be humanely destroyed in line with existing regulations. The other horses on the premises will be subject to epidemiological investigation in the coming weeks. A further two horses have also been under investigation and test results have proved negative.

The animals arrived in a group of 10 horses, nine of which originated from Romania and one from Belgium. The nine Romanian horses were tested for EIA as part of routine post-import testing. Seven horses all tested negative. The horse that originated in Belgium is due to be tested shortly.

Chief Veterinary Officer, Nigel Gibbens said: "This is the first case of equine infectious anaemia infected animals being imported into Great Britain since 1976 and shows the success of our post import testing regime. These were apparently healthy horses carrying a notifiable disease that we are keen to keep out of Great Britain. After considering the risk I have decided to take appropriate action and humanely destroy these two horses that tested positive."

The RCVS has launched a consultation about Schedule 3 of the Veterinary Surgeons Act, which defines what acts of veterinary surgery can be performed by veterinary nurses.

For veterinary nurses, Schedule 3 is arguably one of the most important aspects of the Veterinary Surgeons Act, partly defining what it means to be a nurse, and defining what tasks veterinary surgeons can reasonably delegate. 

Thus far, however, Schedule 3 has only been loosely defined, allowing for veterinary nurses to (under the direction of their veterinary surgeon employer) 'give medical treatment or carry out acts of minor surgery, not involving entry into a body cavity'.

There is evidence from the RCVS/BVNA VN Futures project that uncertainty about what this definition actually means in practice has stopped veterinary surgeons from delegating tasks which could both improve practice efficiency and make the role of the veterinary nurse more interesting, varied and rewarding. 

The consultation - and the broader review of Schedule 3 of which it forms a part - aims to create a 'clarified and bolstered VN role via a reformed Schedule 3'.

Liz Cox, Chair of both the Schedule 3 Working Party and VN Council, said: "The future of veterinary nursing is both challenging and exciting, with the convergence of such factors as Brexit, the development of new technologies, and the increasing specialisation of veterinary surgeons, and we would very much like to know how you think the role of veterinary nurse will evolve.

"In light of this we very much encourage all veterinary nurses and veterinary surgeons to complete this consultation. Evidence gathered during the initial stage of the VN Futures project suggested that there is some uncertainty around the interpretation of Schedule 3 in clinical practice. For example, many veterinary nurses do not undertake Schedule 3 work or are uncertain as to whether they do, while some veterinary surgeons are reluctant to delegate Schedule 3 tasks to veterinary nurses.

"With this survey we hope to get a better steer on how Schedule 3 is used and interpreted in practice on a day-to-day basis and gather views on where both veterinary surgeons and veterinary nurses feel the current legislation could be clarified. Furthermore, we also want to know if there are areas of practice that are currently prohibited to nurses under current Schedule 3 arrangements that the professions believe could be opened up to veterinary nurses as a means of bolstering the profession."

Liz Cox and David Catlow MRCVS, Chair of the Standards Committee, will also be presenting a webinar on Thursday 11 May from 1pm to 2pm titled ‘The Art of Delegation – Schedule 3 Consultation’. It will focus on Schedule 3 and the role of the veterinary nurse, and explore possible areas to consider when responding to the consultation. To subscribe to the webinar, please visit The Webinar Vet’s website: www.thewebinarvet.com/webinar/art-delegation-schedule-3-consultation/

All eligible veterinary nurses and veterinary surgeons have been emailed with a link to survey.

Further information about the VN Futures project can be found at www.vetfutures.org.uk/vnfutures

Zoetis has presented six extracts which, it says, contribute to the body of evidence supporting the use of Lokivetmab, a therapeutic antibody for the treatment of canine atopic dermatitis. 

Zoetis says Lokivetmab targets and neutralizes canine interleukin-31 (IL-31), a cytokine associated with atopic dermatitis which sends the itch signal to the brain.

The company has submitted an application for marketing authorisation of the product, which is conditionally licensed in the US and Canada under the name Canine Atopic Dermatitis Immunotherapeutic, in the European Union. 

The new data was presented at the 8^th World Congress of Veterinary Dermatology (WCVD).  

Supporting the efficacy of Lokivetmab in canine AD, Zoetis presented the results of a randomized, double-blind, placebo-controlled dose determination trial to evaluate efficacy of three doses of lokivetmab (0.125, 0.5 or 2.0 mg/kg) in providing relief from the clinical signs of pruritus (itching) and other clinical signs associated with atopic dermatitis in dogs.

Veterinary investigators at 15 clinics enrolled 245 client-owned, live-at-home dogs with chronic atopic dermatitis. Lokivetmab or a placebo was administered by subcutaneous injection on day 0, and efficacy was evaluated periodically over 56 days. Dog owners assessed their dog’s pruritus using a visual analog scale (VAS), and investigators assessed the associated skin lesions using Canine Atopic Dermatitis Extent and Severity Index-03 (CADESI-03) scores.

Lokivetmab, injected once subcutaneously, provided dose-dependent improvement in owner-assessed pruritus and clinician-assessed CADESI-03 scores for four to six weeks in dogs with atopic dermatitis. 

Zoetis also presented results of a randomized, double-blind, placebo-controlled trial to assess the safety of lokivetmab at the nominal dose tested of 1 mg/kg (range, 1-3.3 mg/kg) in the treatment of canine atopic dermatitis. Veterinary surgeons evaluated 245 client-owned, live-at-home dogs with chronic, naturally-occurring atopic dermatitis. These dogs were randomized at a 2:1 ratio to receive two monthly injections of lokivetmab (162 dogs) or placebo on days 0 and 28.

No immediate hypersensitivity reactions were observed and there were no clinically important differences in clinical pathology results. No apparent adverse drug interactions were reported. Dogs studied were taking a wide variety of medications, which is important because multimodal therapy is commonly prescribed for dogs with atopic dermatitis. Adverse events were reported at a similar frequency between the groups.

Heiniger has launched a new clipper for farm vets called Opal Xtend.

The company says the battery-operated, dual-speed clipper has been specifically designed for a close cut to improve hygiene and make treatments easier.

Hefin Rowlands from Heiniger said: “The Opal Xtend will help vets with accurate hair removal for everyday tasks such as TB testing.

"It has been developed to be quieter, which will reduce stress, and has an interchangeable battery system to enable uninterrupted operation during periods of extensive use.

“An LED battery indicator provides forewarning to operators and additional batteries can be swapped out quickly and easily.

"Each battery will last up to 4 hours and the second battery only takes just over an hour to recharge.”

Heiniger claims that at 415 grams, the clipper is one of the lightest cordless models available.

Hefin added: “It is particularly well suited to preparing animals for skin testing, wound treatments and scans including ultrasounds.”

Heiniger says the clipper is also a good fit for agricultural and equine users looking for a reliable and dependable machine that can stand up to demanding use.

https://www.heiniger.co.uk/product/opal-xtend/ 

The Animal Health Trust (AHT) has - in partnership with UK and Icelandic research and veterinary institutions - helped identify the cause of a mystery respiratory disease epidemic which infected Iceland’s native horse population and also dogs, cats and humans.

The epidemic of respiratory disease in early 2010 was characterised by coughing and nasal discharge.

The disease spread through the population of 77,000 Icelandic horses within weeks, leading to a self-imposed ban on their export and significant economic cost to the country.

Initially, due to the speed at which the disease had spread, a viral cause was suspected. However, investigations by researchers at the University of Iceland showed that only Streptococcus zooepidemicus was consistently recovered from coughing horses and rare fatal cases of infection. However, this bacterium is also often found in healthy horses.

The AHT and the Wellcome Trust Sanger Institute were brought in to investigate. Dr Simon Harris from the Wellcome Trust Sanger Institute said: "To identify the culprit, we sequenced the DNA from 257 samples of bacteria from diseased animals and people. This showed that one specific strain of S. zooepidemicus, called ST209, was the likely culprit, and we also found this strain in a human case of blood poisoning. This study highlights, for the first time, how DNA sequencing can be used to identify endemic strains of bacteria and distinguish them from the cause of an epidemic infection."

Iceland is free of all major equine infectious diseases thanks to the ban on the importation of horses into the country in 1882. Consequently, Icelandic horses are particularly susceptible to any new bacteria or virus that crosses the border, and so strict biosecurity regulations are in place to help protect them.

Dr. Sigríður Björnsdóttir of the MAST Icelandic Food and Veterinary Authority, used information from owners and veterinary surgeons to build an epidemiological network. This enabled her to identify an equine rehabilitation centre where horses exercised in a water treadmill. The water treadmill is thought to have provided the perfect conditions for transmitting the disease as water was splashed up and ingested. Horses would complete their rehabilitation and return home, whilst incubating the disease, taking the infection with them.

The ST209 strain of S. zooepidemicus found in Iceland has also been recovered from a coughing horse in Sweden and an abdominal abscess in a Finnish horse trainer.

Dr Andrew Waller, Head of Bacteriology at the AHT, said: "There are a couple of theories as to how the strain entered Iceland. These bacteria are able to survive outside a horse for a week or so, which means the import of contaminated equipment or clothing is the most likely route by which ST209 entered Iceland. However, this particular strain could have even infected a human who travelled to Iceland, before spreading the strain back to a horse and triggering the epidemic.

"We are delighted to have helped uncover the likely identity of the cause of this epidemic. Our investigation highlights the ability of S. zooepidemicus strains to cause disease in animals and people. We found evidence that even endemic strains of S. zooepidemicus were likely causing cases of respiratory disease in Icelandic horses, illustrating that this group of bacteria causes more clinical problems in horses than was previously thought. We hope that raising awareness of the cause of this epidemic, and the likely involvement of a water treadmill as a key factor in disease transmission, will encourage veterinarians around the world to improve disease control precautions preventing future epidemics."

The BVA, the British Cattle Veterinary Association (BCVA), the Goat Veterinary Society (GVS) and the British Veterinary Poultry Association (BVPA) have launched a new policy position addressing the issues surrounding surplus male animals on farms, recommending that we all eat more UK veal and goat meat to help reduce the slaughter of unwanted male calves and goats.

Current estimates suggest that around 95,000 calves, 30 million chicks and 3,000 Billy kids are affected per year. 

The new position calls for solutions based on the overarching principle that quality of life should take precedence over lifespan, with the longer-term aim to move away from the production of unwanted animals all together. In the meantime, the position calls for further research into solutions to reduce numbers of additional male offspring and for humane methods of killing surplus animals on-farm.

The dairy and egg industries have been advised to adopt a ‘3Rs’ (reduce, replace, refine) approach to the rearing and slaughter of animals which are surplus to the requirements of the specific industries. Reduction recommendations include selecting for sex (a technology used quite frequently within the dairy farming community) and increasing the length of time that an animal can produce milk through selective breeding.

In the absence of these options, the position recommends raising male offspring for meat, with the caveat that calves and billy goat kids should be raised within UK high welfare schemes only.

In the absence of any reduce or replacement options, veterinary experts advise that killing should be undertaken in the most humane way and that all the animal’s welfare needs must be addressed prior to slaughter.

In line with BVA’s sustainable animal agriculture position, this policy recommends that when animals are killed, every effort should be made to make sure that the carcass is used. For example, the carcasses of male chicks killed by controlled atmospheric stunning can be used in animal feed, such as for reptiles and birds of prey.

BVA Junior Vice President, James Russell (pictured right) said: "Unwanted male production animals in the dairy and meat industries are an ethical challenge on a number of levels. Firstly, for the producer who may have animals with little or no commercial value. Secondly, for the consumer who may find the notion of these unused animals a difficulty. Our new joint position is based around the principle of ‘a life worth living’ and looks at ways that the veterinary profession can work with the farming community to reduce the numbers of animals that this affects and ensure that high welfare is always front and centre.

"If slaughter of affected animals is undertaken humanely, it is not a welfare harm per se, but greater measures should be taken to make sure that these decisions are made with minimal carcass wastage and an eye to the economic, emotional and environmental impact at a farm level.

"With greater public understanding of ethical and animal welfare issues faced by the industry, the promotion of farm assurance schemes and further research into alternative breeding options such as selective sex technology, we hope to reduce these numbers and improve the welfare of the animals involved."

BCVA President, Professor David Barrett said: "The number of unwanted male dairy calves has fallen substantially in recent years, due in part to more efficient milk production meaning we now need fewer dairy cows to produce the same volume of milk, as well as the use of breeding technologies that mean we can select for female calves. Nevertheless, surplus males are still produced. Provided these calves’ welfare is protected they should become part of the meat production supply chain either as high-quality UK farm assured veal or beef."

"As we strive for improved sustainability and increase efficient use of resource in food production, we need to use every product from dairying, including calves that can be reared for meat. Our entire industry needs to work together to create a robust supply chains for high quality, farm assured British dairy beef and veal and we need to help consumers understand they should embrace these products. They are very different from intensively reared veal of the type produced in systems previously banned in the UK."

The RCVS is seeking feedback on a new draft Code of Professional Conduct.

The new Code, which would replace the existing RCVS Guide to Professional Conduct for Veterinary Surgeons, has been produced by a Working Party set up by the RCVS Advisory Committee to review the Guides for both veterinary surgeons and veterinary nurses.

According to the College, the purpose of the review, which last took place over a decade ago, is to ensure guidance to the profession and the public is clear. For example, using consistent language to distinguish between what must be done and what is advised.

The RCVS says the new Code is a short, principles-based document using the Federation of Veterinarians of Europe's Code of Conduct as the starting point. It will be supported by additional advice on specific areas of veterinary practice or issues, for example, clinical governance. It also includes:

• a compulsory continuing professional development requirement
• the RCVS Health Protocol
• more on clinical competence, and greater prominence given to relevant medicines issues
• an updated declaration to be made by veterinary surgeons, which gives increased emphasis to animal welfare

Clare Tapsfield-Wright, Chairman of the Guides Review Working Party said: "Over the decade or so since it was last reviewed, not only has the Guide become unwieldy in places, but the way that regulators in general publish professional conduct rules has changed. Our draft new Code aims to clarify matters and bring us into line with best practice elsewhere.

"Animal owners are increasingly keen to understand the basis of what the veterinary profession considers to be good professional conduct. The new simplified Code should assist with this understanding."

The new Code, together with the consultation paper, can be downloaded at http://www.rcvs.org.uk/codeconsultation

Comments, which are welcomed from the profession and the public, should be sent by email to Christopher Murdoch, Secretary to the Guides Review Working Party, at c.murdoch@rcvs.org.uk by Friday, 24 June 2011.

A separate document is under development for veterinary nurses, which will share broadly similar underlying principles and will be the subject of its own consultation.